Literature DB >> 33637809

Influence of bound dodecanoic acid on the reconstitution of albumin nanoparticles from a lyophilized state.

Christian C E Luebbert1, Rola Mansa2, Raisa Rahman1,3, Zygmunt J Jakubek2, Grant E Frahm1, Shan Zou2,3, Michael J W Johnston4,5.   

Abstract

The development of reference standards for nanoparticle sizing allows for cross laboratory studies and effective transfer of particle sizing methodology. To facilitate this, these reference standards must be stable upon long-term storage. Here, we examine factors that influence the properties of cross-linked albumin nanoparticles, fabricated with an ethanol desolvation method, when reconstituted from a lyophilized state. We demonstrate, with nanoparticle tracking analysis, no significant changes in mean particle diameter upon reconstitution of albumin nanoparticles fabricated with bovine serum albumin loaded with dodecanoic acid, when compared to nanoparticles fabricated with a fatty acid-free BSA. We attribute this stability to the modulation of nanoparticle charge-charge interactions at dodecanoic acid specific binding locations. Furthermore, we demonstrate this in a lyophilized state over six months when stored at - 80 °C. We also show that the reconstitution process is readily transferable between technicians and laboratories and further confirm our finding with dynamic light scattering analysis.

Entities:  

Year:  2021        PMID: 33637809      PMCID: PMC7910568          DOI: 10.1038/s41598-021-84131-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  33 in total

1.  Albumin nanoparticles with predictable size by desolvation procedure.

Authors:  B von Storp; A Engel; A Boeker; M Ploeger; K Langer
Journal:  J Microencapsul       Date:  2012       Impact factor: 3.142

Review 2.  Liposomal drug delivery systems: from concept to clinical applications.

Authors:  Theresa M Allen; Pieter R Cullis
Journal:  Adv Drug Deliv Rev       Date:  2012-10-01       Impact factor: 15.470

3.  Minicapsules encapsulating nanoparticles for targeting, apoptosis induction and treatment of colon cancer.

Authors:  Aakanchha Jain; Richa Jain; Sourabh Jain; Renuka Khatik; Dharam Veer Kohli
Journal:  Artif Cells Nanomed Biotechnol       Date:  2019-12       Impact factor: 5.678

4.  Systematic study on the preparation of BSA nanoparticles.

Authors:  F Galisteo-González; J A Molina-Bolívar
Journal:  Colloids Surf B Biointerfaces       Date:  2014-09-22       Impact factor: 5.268

5.  The similarity question for biologicals and non-biological complex drugs.

Authors:  Daan J A Crommelin; Vinod P Shah; Imre Klebovich; Scott E McNeil; Vera Weinstein; Beat Flühmann; Stefan Mühlebach; Jon S B de Vlieger
Journal:  Eur J Pharm Sci       Date:  2015-04-23       Impact factor: 4.384

Review 6.  How to regulate nonbiological complex drugs (NBCD) and their follow-on versions: points to consider.

Authors:  Huub Schellekens; Sven Stegemann; Vera Weinstein; Jon S B de Vlieger; Beat Flühmann; Stefan Mühlebach; Rogério Gaspar; Vinod P Shah; Daan J A Crommelin
Journal:  AAPS J       Date:  2013-09-25       Impact factor: 4.009

7.  Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.

Authors:  K Langer; M G Anhorn; I Steinhauser; S Dreis; D Celebi; N Schrickel; S Faust; V Vogel
Journal:  Int J Pharm       Date:  2007-06-23       Impact factor: 5.875

8.  Nanoparticle size and production efficiency are affected by the presence of fatty acids during albumin nanoparticle fabrication.

Authors:  Christian C Luebbert; Tessa M Clarke; Roberta Pointet; Grant E Frahm; Sharon Tam; Barry Lorbetskie; Simon Sauvé; Michael J W Johnston
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

Review 9.  Chronic Hepatitis B Infection: A Review.

Authors:  Lydia S Y Tang; Emily Covert; Eleanor Wilson; Shyam Kottilil
Journal:  JAMA       Date:  2018-05-01       Impact factor: 56.272

Review 10.  Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.

Authors:  Yi Gou; Dandan Miao; Min Zhou; Lijuan Wang; Hongyu Zhou; Gaoxing Su
Journal:  Front Pharmacol       Date:  2018-04-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.